Corcept Therapeutics, Inc. (CORT)
34.73
-0.66
(-1.86%)
USD |
NASDAQ |
Jan 16, 16:00
34.77
+0.04
(+0.12%)
After-Hours: 20:00
Corcept Therapeutics Total Liabilities (Quarterly): 191.70M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Axsome Therapeutics, Inc. | 595.52M |
| Johnson & Johnson | 113.54B |
| United Therapeutics Corp. | 760.90M |
| Ultragenyx Pharmaceutical, Inc. | 1.174B |
| Amicus Therapeutics, Inc. | 638.39M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 823.61M |
| Shareholders Equity (Quarterly) | 631.90M |
| Debt to Equity Ratio | 0.0101 |
| Current Ratio | 3.141 |
| Net Debt Paydown Yield | -0.00% |